Research progress of body fluid piRNA as a potential biomarker of disease

doi:10.3969/j.issn.1673-8640.2022.08.015

Abstract

Abstract:

PIWI-interacting RNA（piRNA）is a new class of small non-coding RNA that can silence transposon and regulate mRNA translation. Previous studies have shown that piRNA is mainly involved in germ cell development and spermatogenesis,and it is closely related to tumorigenesis and other diseases. The differential expression levels of piRNA in body fluid under specific disease states suggest that piRNA have the potential to be a new biomarker. The review focuses on the progress of research on body fluid piRNA as a potential biomarker for various diseases.

Key words: PIWI-interacting RNA, Body fluid, Biomarker

CLC Number:

R446.7

WU Yanqian, YU Chong, SHEN Lu, ZHENG Haoran, HONG Yeting. Research progress of body fluid piRNA as a potential biomarker of disease[J]. Laboratory Medicine, 2022, 37(8): 782-786.

Figures/Tables 1

References 38

[1]	ARAVIN A, GAIDATZIS D, PFEFFER S, et al. A novel class of small RNAs bind to MILI protein in mouse testes[J]. Nature, 2006, 442(7099):203-207. DOI URL
[2]	GIRARD A, SACHIDANANDAM R, HANNON G J, et al. A germline-specific class of small RNAs binds mammalian Piwi proteins[J]. Nature, 2006, 442(7099):199-202. DOI URL
[3]	KIRINO Y, MOURELATOS Z. Mouse Piwi-interacting RNAs are 2'-O-methylated at their 3' termini[J]. Nat Struct Mol Biol, 2007, 14(4):347-348. DOI URL
[4]	OZATA D M, GAINETDINOV I, ZOCH A, et al. PIWI-interacting RNAs:small RNAs with big functions[J]. Nat Rev Genet, 2019, 20(2):89-108.
[5]	石硕, 王晨, 林海帆. PIWI/piRNA在癌症中的功能和机制[J]. 自然杂志, 2021, 43(5):313-322.
[6]	沈鹭, 俞翀, 高方, 等. PIWI/piRNA复合体调控精子发生的研究进展[J]. 中华男科学杂志, 2021, 27(3):262-268.
[7]	HUANG X, YUAN T, TSCHANNEN M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing[J]. BMC Genomics, 2013, 14:319. DOI URL
[8]	FREEDMAN J E, GERSTEIN M, MICK E, et al. Diverse human extracellular RNAs are widely detected in human plasma[J]. Nat Commun, 2016, 7:11106. DOI URL
[9]	YUAN T, HUANG X, WOODCOCK M, et al. Plasma extracellular RNA profiles in healthy and cancer patients[J]. Sci Rep, 2016, 6:19413. DOI URL
[10]	BAHN J H, ZHANG Q, LI F, et al. The landscape of microRNA,Piwi-interacting RNA,and circular RNA in human saliva[J]. Clin Chem, 2015, 61(1):221-230. DOI URL
[11]	HONG Y, WANG C, FU Z, et al. Systematic characterization of seminal plasma piRNAs as molecular biomarkers for male infertility[J]. Sci Rep, 2016, 6:24229. DOI URL
[12]	EL-MOGY M, LAM B, HAJ-AHMAD T A, et al. Diversity and signature of small RNA in different bodily fluids using next generation sequencing[J]. BMC Genomics, 2018, 19(1):408. DOI URL
[13]	HONG Y, WU Y, ZHANG J, et al. Decreased piRNAs in infertile semen are related to downregulation of sperm MitoPLD expression[J]. Front Endocrinol(Lausanne), 2021, 12:696121.
[14]	CUI L, LOU Y, ZHANG X, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers[J]. Clin Biochem, 2011, 44(13):1050-1057. DOI URL
[15]	GU X, WANG C, DENG H, et al. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma[J]. Acta Biochim Biophys Sin(Shanghai), 2020, 52(5):475-484.
[16]	GU X, WANG C, DENG H, et al. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma[J]. Acta Biochim Biophys Sin(Shanghai), 2020, 52(5):475-484.
[17]	QU A, WANG W, YANG Y, et al. A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer[J]. Cancer Manag Res, 2019, 11:3703-3720. DOI URL
[18]	MAI D, DING P, TAN L, et al. PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma[J]. Theranostics, 2018, 8(19):5213-5230. DOI URL
[19]	MAI D, ZHENG Y, GUO H, et al. Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of human colorectal cancer[J]. Theranostics, 2020, 10(19):8468-8478. DOI URL
[20]	SABBAH N A, ABDALLA W M, MAWLA W A, et al. PiRNA-823 is a unique potential diagnostic non-invasive biomarker in colorectal cancer patients[J]. Genes(Basel), 2021, 12(4):598.
[21]	WANG Z, YANG H, MA D, et al. Serum PIWI-interacting RNAs piR-020619 and piR-020450 are promising novel biomarkers for early detection of colorectal cancer[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(5):990-998. DOI URL
[22]	CORDEIRO A, NAVARRO A, GAYA A, et al. PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma[J]. Oncotarget, 2016, 7(29):46002-46013. DOI URL
[23]	YAN H, WU Q L, SUN C Y, et al. piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma[J]. Leukemia, 2015, 29(1):196-206. DOI URL
[24]	LI B, HONG J, HONG M, et al. piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment[J]. Oncogene, 2019, 38(26):5227-5238. DOI URL
[25]	MA H, WANG H, TIAN F, et al. PIWI-interacting RNA-004800 is regulated by S1P receptor signaling pathway to keep myeloma cell survival[J]. Front Oncol, 2020, 10:438. DOI URL
[26]	YANG J, XUE F T, LI Y Y, et al. Exosomal piRNA sequencing reveals differences between heart failure and healthy patients[J]. Eur Rev Med Pharmacol Sci, 2018, 22(22):7952-7961.
[27]	SUNDAR I K, LI D, RAHMAN I. Small RNA-sequence analysis of plasma-derived extracellular vesicle miRNAs in smokers and patients with chronic obstructive pulmonary disease as circulating biomarkers[J]. J Extracell Vesicles, 2019, 8(1):1684816.
[28]	JIA S, ZHANG Q, WANG Y, et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate[J]. EBioMedicine, 2021, 65:103253.
[29]	SABO A A, BIROLO G, NACCARATI A, et al. Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing:expression levels of miR-126-3p and piR-5936 increase with higher histologic grades[J]. Cancers(Basel), 2020, 12(6):1507.
[30]	KUMAR K, TRZYBULSKA D, TSATSANIS C, et al. Identification of circulating small non-coding RNAs in relation to male subfertility and reproductive hormones[J]. Mol Cell Endocrinol, 2019, 492:110443. DOI URL
[31]	VOJTECH L, WOO S, HUGHES S, et al. Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions[J]. Nucleic Acids Res, 2014, 42(11):7290-7304. DOI URL
[32]	CHEN H, XIE Y, LI Y, et al. Outcome prediction of microdissection testicular sperm extraction based on extracellular vesicles piRNAs[J]. J Assist Reprod Genet, 2021, 38(6):1429-1439. DOI URL
[33]	NAGIRNAJA L, MØRUP N, NIELSEN J E, et al. Variant PNLDC1,defective piRNA processing,and azoospermia[J]. N Engl J Med, 2021, 385(8):707-719. DOI URL
[34]	ILIEV R, FEDORKO M, MACHACKOVA T, et al. Expression levels of PIWIinteracting RNA,piR-823,are deregulated in tumor tissue,blood serum and urine of patients with renal cell carcinoma[J]. Anticancer Research, 2016, 36(12):6419-6424. DOI URL
[35]	MARKERT L, HOLDMANN J, KLINGER C, et al. Small RNAs as biomarkers to differentiate benign and malign prostate diseases:an alternative for transrectal punch biopsy of the prostate?[J]. PLoS One, 2021, 16(3):e0247930.
[36]	HE L, PING F, FAN Z, et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening[J]. Biomed Pharmacother, 2020, 121:109553. DOI URL
[37]	ZHAO S Y, WANG J, OUYANG S B, et al. Salivary circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as novel biomarkers for the diagnosis of oral squamous cell carcinoma[J]. Cell Physiol Biochem, 2018, 47(6):2511-2521. DOI URL
[38]	LI K, LIN Y, LUO Y, et al. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma:a multicenter prospective study[J]. Mol Cancer, 2022, 21(1):21. DOI URL

样本类型	piRNA	疾病	表达量	临床分析
外周血	piR-651、piR-823	胃癌	降低	TNM分期和远隔转移
外周血	piR-5937、piR-28876	结直肠癌	降低	诊断、TNM分期
外周血	piR-017724	结直肠癌	降低	诊断和预后
外周血	piR-54265	结直肠癌	升高	筛查、早期检测和临床监测
外周血	piR-020619、piR-020450	结直肠癌	升高	早期检测
外周血	piR-823	结直肠癌	升高	诊断TNM分期
外周血	piR-10506469、piR-20548188	胆管癌和胆囊癌	升高	诊断和预后
外周血	piR-651	霍奇金淋巴瘤	降低	评估生存期和预后
外周血	piR-823	多发性骨髓瘤	升高	诊断、分期和预后
外周血	piR-020009、piR-006426	心力衰竭	降低	诊断
外周血	piR-012753、piR-016735	慢性阻塞性肺疾病	升高	区分慢性阻塞性肺疾病患者与吸烟者、非吸烟者
外周血	piR-009228、piR-016659、piR-020496	非综合征型唇腭裂	升高	产前筛查畸形儿
外周血	piR-5936	膀胱癌	升高	膀胱癌风险等级评估
外周血	piR-26399	男性不育	升高	诊断
精浆	piR-1207、piR-2107	弱精症	降低	诊断
精浆	piR-61927	非梗阻性无精症	降低	睾丸显微取精术结果评估
尿液	piR-823	肾细胞肾癌	升高	诊断
尿液	piR-018849、piR-019324	前列腺疾病	降低	鉴别前列腺增生和前列腺癌
骨髓上清液	piR-004800	多发性骨髓瘤	升高	多发性骨髓瘤分期

样本类型	piRNA	疾病	表达量	临床分析
外周血	piR-651、piR-823	胃癌	降低	TNM分期和远隔转移
外周血	piR-5937、piR-28876	结直肠癌	降低	诊断、TNM分期
外周血	piR-017724	结直肠癌	降低	诊断和预后
外周血	piR-54265	结直肠癌	升高	筛查、早期检测和临床监测
外周血	piR-020619、piR-020450	结直肠癌	升高	早期检测
外周血	piR-823	结直肠癌	升高	诊断TNM分期
外周血	piR-10506469、piR-20548188	胆管癌和胆囊癌	升高	诊断和预后
外周血	piR-651	霍奇金淋巴瘤	降低	评估生存期和预后
外周血	piR-823	多发性骨髓瘤	升高	诊断、分期和预后
外周血	piR-020009、piR-006426	心力衰竭	降低	诊断
外周血	piR-012753、piR-016735	慢性阻塞性肺疾病	升高	区分慢性阻塞性肺疾病患者与吸烟者、非吸烟者
外周血	piR-009228、piR-016659、piR-020496	非综合征型唇腭裂	升高	产前筛查畸形儿
外周血	piR-5936	膀胱癌	升高	膀胱癌风险等级评估
外周血	piR-26399	男性不育	升高	诊断
精浆	piR-1207、piR-2107	弱精症	降低	诊断
精浆	piR-61927	非梗阻性无精症	降低	睾丸显微取精术结果评估
尿液	piR-823	肾细胞肾癌	升高	诊断
尿液	piR-018849、piR-019324	前列腺疾病	降低	鉴别前列腺增生和前列腺癌
骨髓上清液	piR-004800	多发性骨髓瘤	升高	多发性骨髓瘤分期